Viridian Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92790C1045
USD
29.17
14.31 (96.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryViridian Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
96.3%
-0.51%
1W
101.87%
-1.37%
1M
135.43%
0.35%
YTD
52.16%
0.54%
1Y
138.71%
13.99%
3Y
168.35%
66.39%
5Y
86.99%
77.77%
10Y
86.99%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
87.23%
0%
87.23%
6 Months
50.67%
0%
50.67%
1 Year
138.71%
0%
138.71%
2 Years
14.3%
0%
14.3%
3 Years
168.35%
0%
168.35%
4 Years
82.31%
0%
82.31%
5 Years
86.99%
0%
86.99%

Viridian Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary